Pertinax Pharma are delighted to announce that Simon Hubbert has joined the Board of Directors as Non- Executive Chairman. Simon has over 25 years’ experience in the medical device industry and has held CEO, senior commercial and general management position in both public and private global medtech companies including Johnson & Johnson, Medtronic, Lombard Medical and LMA International.
Pertinax’s CEO, Michele Barbour, said “We are very excited about working with Simon to take the company into the medical device market. Simon’s extensive, in depth knowledge of market dynamics and his bold approach are the perfect complement for our disruptive technology.
Simon said “I’m delighted to be invited to join the board of Pertinax Pharma. Pertinax has developed a very compelling antimicrobial compound which has the potential to protect patients from infection associated with medical devices. This is a high focus area for medical device companies and health care providers around the world.